Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Tritanrix-HepB/Hib-MenAC vs Tritanrix-HepB/Hiberix in Healthy Infants
NCT00317187Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2004
- Primary completion
- Jan 2005
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Hib + MenAC in meningococcal disease, Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Jun 2004; status: completed.
02
Drugs
Hib + MenAC
03
Conditions
meningococcal diseaseHaemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT00317187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317187.